Navigation Links
Little known pregnancy disease, Hyperemesis Gravidarum, receives awareness with a $20,000 donation from the H.E.R. Foundation to begin Genome Research at UCLA
Date:7/9/2012

LEESBURG, Va., July 9, 2012 /PRNewswire-iReach/ -- The HER Foundation (Hyperemesis Education & Research), the voice of HG, presented $20,000 to UCLA's medical research department and the Hyperemesis Gravidarum Genome Project. Hyperemesis Gravidarum (HG) is a debilitating and potentially life-threatening pregnancy disease marked by rapid weight loss, malnutrition, and dehydration due to unrelenting nausea and/or vomiting with potential adverse consequences for the newborn(s). HG is the second leading cause of hospitalization during pregnancy, yet few dollars are granted for research.

The research, conducted by lead researcher Dr. Marlena Fejzo, will focus on identifying the gene associated with Hyperemesis Gravidarum (HG), and how the effects of this disease, brought on by pregnancy, affect the mother and child.  Dr. Fejzo states, "The latest award of $20,000 from the HER Foundation will enable us to use an exciting novel technology to identify the gene(s) and corresponding biological pathways related to HG in HG-families." 

Kimber MacGibbon, co-founder of the HER Foundation says, "We are very excited to support this important genetic study that will give us greater understanding of Hyperemesis Gravidarum, as well as the opportunity to identify mothers at risk for HG so they can receive proactive care. Ultimately, this study will improve the care of those with HG and disprove the erroneous beliefs about the cause of HG."

The national cost of treating HG in the inpatient setting increased 50% from $167 million in 2000 to $250 million in 2009. Recent studies show HG is associated with low birth weight, intrauterine growth restriction, preterm delivery, and fetal and neonatal death.  Elective pregnancy termination in a large cohort of women with Hyperemesis Gravidarum have also been shown in recent studies. Recurren
'/>"/>

SOURCE The HER Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medzilla.com Special Report: Unemployed Can Breathe a Little Freer After Supreme Court's Affordable Care Act Ruling
2. Study dusts sugar coating off little-known regulation in cells
3. Eczema in Babies Due to Stress in Pregnancy
4. Morning Sickness or NVP: National Survey of Nurse Practitioners Points to Underreporting of Common Condition in Pregnancy
5. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
6. Lupin Receives FDA Approval for Generic LYRICA(R)
7. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
8. Synedgen’s Synoplex® Receives FDA Indexing for Use in the Treatment of Chronic Wounds in Pachyderms
9. Nourish the World! Terra Biotech Receives Thanks and Praise After First Shipment of 10,000 Servings of Nectr Core Vitamin Powder to Orphans in Ghana, Africa
10. PharmaDirections Succeeds Through its Client’s Successes: Cortendo Receives Positive Orphan Drug Opinion from EMA for NormoCort for Cushing’s Disease
11. Exotic Automation & Supply Receives Ford’s 2011 World Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... of last week RENU 28, the world's first and only ... purchase in Australia and New Zealand, and the response has ... if you think about the definition of aging, it's really ... your body. If you think about the definition of anti-aging, ... RENU 28 does is it works with these tiny little ...
(Date:8/20/2014)... 2014 Neurotrope, Inc. (OTCQB: NTRP) today ... to provide an update on Company activities. Access ... numbers:(888) 505-4369 (U.S. and Canada) or (719) 325-2315 ... , under "Investor Relations"The teleconference replay will be ... 2, 2014 at (888) 203-1112 (U.S. and ...
(Date:8/20/2014)... August 20, 2014 Not long ago, ... studies should be performed late in the development cycle ... But current regulatory trends suggest that, like many things ... rise. In recent years, multiple drug sponsors have been ... address specific questions during phase I/II. It’s not only ...
(Date:8/19/2014)... Piscataway, NJ (PRWEB) August 20, 2014 ... engineering and regenerative medicine is an inadequate vascular ... engineered constructs and decellularized tissues is critical for ... Researchers have attempted to mitigate deficiencies in vascularization ... including adding scaffold bioactivity, optimizing scaffold design and ...
Breaking Biology Technology:RENU 28 Skin Care Now Available in Australia and New Zealand 2Neurotrope To Host Conference Call 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2
... May 12 Aton Pharma, Inc., a global,specialty ... a,distribution agreement with Meizler Biopharma S/A to commercialize,CUPRIMINE(R) ... in,Brazil, and Meizler is working to obtain regulatory ... medically essential products, and Aton is,committed to making ...
... Poised to Impact Lung Cancer Care, ST. ... medical,device start-up company, has secured $4.75M in venture ... IG4 delivery system for minimally,invasive biopsy and ablation ... and was joined by Advantage Capital Partners and ...
... (NYSE:,CVD) today announced that it will present at the ... 2008 at 10:30 am ET. Investors may,access a live ... order to,register and download any necessary software, please log ... New Jersey, is one of the,world,s largest and most ...
Cached Biology Technology:Aton Pharma Announces Distribution Partnership in Brazil 2Veran Medical Technologies Secures $4.75M in First Institutional Funding 2
(Date:8/19/2014)... Research and Network-Level Science, , Imagine if we had ... ecosystems was responding to global changes in real time. ... coupled multiple decades of information about ecological responses to ... dozens of different ecosystem types. , In fact, ... (LTER) Network, which will soon celebrate its 35th anniversary. ...
(Date:8/19/2014)... leprosy and tuberculosis live side-by-side. Worldwide there are ... with nearly all of them occurring where tuberculosis ... Calmette-Guerin, or BCG, provides only partial protection against ... vaccine is needed to combat both diseases. UCLA-led ... both diseases., In a study published in the ...
(Date:8/19/2014)... devised a new implantable tissue scaffold coated with bone ... weeks. When applied to bone injuries or defects, this ... bone that looks and behaves just like the original ... a dramatic improvement over the current standard for treating ... of the patient,s body a painful process that ...
Breaking Biology News(10 mins):This week from AGU: Long-term ecological research, predicting cholera outbreaks 2New vaccine shows promise as stronger weapon against both tuberculosis and leprosy 2Engineering new bone growth 2Engineering new bone growth 3
... within weeks after a person is infected with the HIV ... Center and the Bernard-Nocht Institute appearing in the international open-access ... mostly found in the digestive tract, tend not to return ... In recent years, HIV infection has been shown to deplete ...
... Oct. 2 tells a tale of "genome archaeology" by ... of maize and rice. Their resulting insights into plant ... genetically modified organism (GMO) controversy. , "Our findings elucidate ... much like modern biotechnologists do. Now we must reassess ...
... the December issue of the journal Cell Metabolism, published ... which the mammary glands of mammals meet the incredible ... of breast development undoubtedly affect breast cancer, the findings ... researchers found that one of three “isoforms?of the gene ...
Cached Biology News:Early HIV treatment fails to restore memory T cells 2Genome archaeology illuminates the genetic engineering debate 2How mammals fuel milk production may have implications for cancer 2How mammals fuel milk production may have implications for cancer 3
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
...
Request Info...
... and miRNA Isolation Traditional mRNA isolation ... and can result in the loss of ... miRNA Isolation Kit purifies all RNA species ... Through an enrichment procedure included in the ...
Biology Products: